OrthoSensor, the Dania Beach-based maker of intelligent orthopaedic devices, raised $19 million in a Series C round of financing. Bridger Healthcare and The Tullis Growth Fund participated in the round, the company said.
The proceeds will be used to drive the commercialization of VERASENSE, OrthoSensor's leading product, and expand product development activities. OrthoSensor produces sensors that deliver data during surgery that help doctors pinpoint the positioning of knee implants to minimize or eliminate complications after surgery. The company markets the disposable sensors through leading sellers of medical devices including Biomet, Stryker and Zimmer Holdings. VERASENSE is a disposable sensor-assisted total knee replacement instrument that delivers data wirelessly and enables surgeons to make evidence-based decisions on ligament/soft tissue balance and implant position in real time.
OrthoSensor, founded in 2008, has already raised more than $53 million in financing, bringing its total funding to about $72 million.